Anna Tokarska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Anna Tokarska has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Agnieszka Waszczuk
The Provincial Specialist Hospital in Biała Podlaska, Terebelska 57-65, 21-500, Biała Podlaska, Poland
6 shared publications - Aleksandra Arnista
Military Institute of Medicine-National Research Institute, Szaserów 128, 04-141, Warsaw, Poland
6 shared publications - Aleksandra Kołodziejczyk
District Hospital in Grójec, 05-600 Piotra Skargi 10, Grójec, Poland
6 shared publications - Katarzyna Gawrońska
Specialized Provincial Hospital in Ciechanów, Powstańców Wielkopolskich 2, 06-400 Ciechanów, Poland
6 shared publications - Marcin Grzebyk
Organmedica, gen. Augusta Emila Fieldorfa „Nila” 10 lok. 317 03-984 Warsaw, Poland
6 shared publications - Mateusz Świątko
District Hospital in Sochaczew, Batalionów Chłopskich 3/7, 96-500 Sochaczew, Poland
6 shared publications
Latest Publications
- Open Access
- 30 June 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 2(46)
THE IMPACT OF PSORIASIS ON MENTAL AND SOCIAL WELL-BEING: A LITERATURE REVIEW FROM A PSYCHODERMATOLOGICAL PERSPECTIVE
Psoriasis, a chronic inflammatory skin disease, poses challenges not only due to its somatic symptoms but also because of its significant impact on patients’ quality of life, mental health, and social and occupational functioning. This review aimed to analyze the multidimensional influence of psoriasis on patients’ psychosocial condition, with particular attention to stigmatization, symptoms of depression and anxiety, suicide risk, and factors affecting quality of life. The analysis is based on up-to-date literature from systematic reviews, cross-sectional and qualitative studies published between 2010 and 2025. Findings indicate that patients with psoriasis are significantly more likely to experience depressive and anxiety disorders, often regardless of lesion severity. Subjective factors such as body image perception, social stigma, loss of control over one’s body, and limitations in professional life play a crucial role. Importantly, some patients exhibit suicidal ideation at early stages of the disease, even before treatment begins. Simultaneously, evidence points to the necessity of an integrated care model that includes dermatological, psychological, and social support. Incorporating mental health and quality of life assessments into routine clinical practice can significantly improve treatment outcomes and patient well-being. This review emphasizes the need for a holistic approach to psoriasis management that addresses not only physical but also psychological and social dimensions.
- 30 June 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 2(46)
Open AccessTHE IMPACT OF PSORIASIS ON MENTAL AND SOCIAL WELL-BEING: A LITERATURE REVIEW FROM A PSYCHODERMATOLOGICAL PERSPECTIVE
Psoriasis, a chronic inflammatory skin disease, poses challenges not only due to its somatic symptoms but also because of its significant impact on patients’ quality of life, mental health, and social and occupational functioning. This review aimed to analyze the multidimensional influence of psoriasis on patients’ psychosocial condition, with particular attention to stigmatization, symptoms of depression and anxiety, suicide risk, and factors affecting quality of life. The analysis is based on up-to-date literature from systematic reviews, cross-sectional and qualitative studies published between 2010 and 2025. Findings indicate that patients with psoriasis are significantly more likely to experience depressive and anxiety disorders, often regardless of lesion severity. Subjective factors such as body image perception, social stigma, loss of control over one’s body, and limitations in professional life play a crucial role. Importantly, some patients exhibit suicidal ideation at early stages of the disease, even before treatment begins. Simultaneously, evidence points to the necessity of an integrated care model that includes dermatological, psychological, and social support. Incorporating mental health and quality of life assessments into routine clinical practice can significantly improve treatment outcomes and patient well-being. This review emphasizes the need for a holistic approach to psoriasis management that addresses not only physical but also psychological and social dimensions.
- 30 June 2025
- Published by European Scientific Society in Archiv Euromedica
- Vol. 15 (3)
Advancements in Health Monitoring: The Role of Wearable Technology and Emerging Solutions - literature review
Aims: This review aims to analyze the impact of advancements in wearable technology and digital health solutions on health monitoring. The study focuses on how these innovations have improved the accuracy of health data collection, expanded access to medical monitoring, and strengthened patient engagement in self-care. Methods: A comprehensive literature review was conducted using publicly available databases, including PubMed, NEJM and Google Scholar, using articles available in English. Studies focusing on wearable health technology, its applications in chronic disease management, and its integration into healthcare systems were analyzed. Results: Wearable health technology has significantly enhanced real-time patient monitoring, enabling earlier detection of health conditions and more personalized treatment strategies. Devices such as smart watches, ECG monitors, and continuous glucose monitors have improved disease management and patient compliance. However, challenges related to data security, device interoperability, and patient adherences remain prevalent. Conclusion: Wearable health technology is transforming healthcare by providing continuous, real-time health monitoring and facilitating early intervention. While its potential is vast, addressing challenges such as data privacy and integration with existing medical systems is crucial for maximizing its benefits. Wearable health technologies are increasingly integrated into medical practice, offering new opportunities for continuous patient monitoring, early disease detection, and personalized treatment.
- 30 June 2025
- Published by European Scientific Society in Archiv Euromedica
- Vol. 15 (3)
Advancements in Health Monitoring: The Role of Wearable Technology and Emerging Solutions - literature review
Aims: This review aims to analyze the impact of advancements in wearable technology and digital health solutions on health monitoring. The study focuses on how these innovations have improved the accuracy of health data collection, expanded access to medical monitoring, and strengthened patient engagement in self-care. Methods: A comprehensive literature review was conducted using publicly available databases, including PubMed, NEJM and Google Scholar, using articles available in English. Studies focusing on wearable health technology, its applications in chronic disease management, and its integration into healthcare systems were analyzed. Results: Wearable health technology has significantly enhanced real-time patient monitoring, enabling earlier detection of health conditions and more personalized treatment strategies. Devices such as smart watches, ECG monitors, and continuous glucose monitors have improved disease management and patient compliance. However, challenges related to data security, device interoperability, and patient adherences remain prevalent. Conclusion: Wearable health technology is transforming healthcare by providing continuous, real-time health monitoring and facilitating early intervention. While its potential is vast, addressing challenges such as data privacy and integration with existing medical systems is crucial for maximizing its benefits. Wearable health technologies are increasingly integrated into medical practice, offering new opportunities for continuous patient monitoring, early disease detection, and personalized treatment.
- 30 June 2025
- Published by European Scientific Society in Archiv Euromedica
- Vol. 15 (3)
Physiotherapy and Physical Activity in Endometriosis-Associated Pain - A Literature Review
Aim: This narrative review aims to evaluate the current scientific evidence on the effectiveness of physiotherapy and physical activity in reducing pain and improving quality of life in women with endometriosis. Methods: A literature search was conducted using PubMed and Google Scholar databases to identify English-language studies published between 2013 and 2024. The search included terms such as “endometriosis”, “physiotherapy”, “exercise”, and “chronic pelvic pain”. The review included randomized controlled trials, observational studies, and clinical guidelines addressing the use of non-pharmacological interventions in endometriosis management. Results: The analysis indicates that various physiotherapeutic techniques, including pelvic floor muscle training, manual therapy, and relaxation strategies, may alleviate pain symptoms, especially in cases of superficial dyspareunia and chronic pelvic pain. Regular physical activity, such as aerobic or stretching exercises, may support hormonal balance, reduce systemic inflammation, and contribute to improved mental health. However, the available evidence is heterogeneous, and methodological limitations of existing studies hinder definitive conclusions. Conclusion: Physiotherapy and physical activity represent promising adjunctive approaches in the treatment of endometriosis, particularly for patients who experience insufficient relief from pharmacological or surgical therapies. Further high-quality, controlled studies are required to establish standardized treatment protocols and confirm the long-term effectiveness of these interventions.
- 30 June 2025
- Published by European Scientific Society in Archiv Euromedica
- Vol. 15 (3)
Physiotherapy and Physical Activity in Endometriosis-Associated Pain - A Literature Review
Aim: This narrative review aims to evaluate the current scientific evidence on the effectiveness of physiotherapy and physical activity in reducing pain and improving quality of life in women with endometriosis. Methods: A literature search was conducted using PubMed and Google Scholar databases to identify English-language studies published between 2013 and 2024. The search included terms such as “endometriosis”, “physiotherapy”, “exercise”, and “chronic pelvic pain”. The review included randomized controlled trials, observational studies, and clinical guidelines addressing the use of non-pharmacological interventions in endometriosis management. Results: The analysis indicates that various physiotherapeutic techniques, including pelvic floor muscle training, manual therapy, and relaxation strategies, may alleviate pain symptoms, especially in cases of superficial dyspareunia and chronic pelvic pain. Regular physical activity, such as aerobic or stretching exercises, may support hormonal balance, reduce systemic inflammation, and contribute to improved mental health. However, the available evidence is heterogeneous, and methodological limitations of existing studies hinder definitive conclusions. Conclusion: Physiotherapy and physical activity represent promising adjunctive approaches in the treatment of endometriosis, particularly for patients who experience insufficient relief from pharmacological or surgical therapies. Further high-quality, controlled studies are required to establish standardized treatment protocols and confirm the long-term effectiveness of these interventions.
- Open Access
- 19 June 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 82, 60447
The role of the gut microbiome in cardiovascular disease
In recent years, the gut microbiome has gained increasing recognition as a crucial modulator of physiological homeostasis, including cardiovascular function. Numerous studies indicate that disruptions in the composition and activity of intestinal microbiota—referred to as dysbiosis—may significantly contribute to the onset and progression of cardiovascular diseases, including atherosclerosis, hypertension, heart failure, and arrhythmias. Particular attention has been paid to microbial metabolites such as trimethylamine-N-oxide (TMAO), short-chain fatty acids (SCFAs), and lipopolysaccharides (LPS), which exert significant effects on inflammatory, immunological, and metabolic pathways. The aim of this review was to synthesize current evidence regarding the association between the gut microbiota and the pathogenesis of cardiovascular disorders, emphasizing potential molecular mechanisms and therapeutic opportunities arising from microbiome modulation. Additionally, environmental, dietary, and pharmacological factors influencing microbiota composition and their implications for cardiovascular risk were discussed. Accumulated evidence suggests the gut microbiome could serve both as a biomarker of cardiovascular risk and as a potential therapeutic target within personalized medicine frameworks. However, further clinical research is required to precisely define its role in the pathogenesis and treatment of cardiovascular diseases.
- 19 June 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 82, 60447
Open AccessThe role of the gut microbiome in cardiovascular disease
In recent years, the gut microbiome has gained increasing recognition as a crucial modulator of physiological homeostasis, including cardiovascular function. Numerous studies indicate that disruptions in the composition and activity of intestinal microbiota—referred to as dysbiosis—may significantly contribute to the onset and progression of cardiovascular diseases, including atherosclerosis, hypertension, heart failure, and arrhythmias. Particular attention has been paid to microbial metabolites such as trimethylamine-N-oxide (TMAO), short-chain fatty acids (SCFAs), and lipopolysaccharides (LPS), which exert significant effects on inflammatory, immunological, and metabolic pathways. The aim of this review was to synthesize current evidence regarding the association between the gut microbiota and the pathogenesis of cardiovascular disorders, emphasizing potential molecular mechanisms and therapeutic opportunities arising from microbiome modulation. Additionally, environmental, dietary, and pharmacological factors influencing microbiota composition and their implications for cardiovascular risk were discussed. Accumulated evidence suggests the gut microbiome could serve both as a biomarker of cardiovascular risk and as a potential therapeutic target within personalized medicine frameworks. However, further clinical research is required to precisely define its role in the pathogenesis and treatment of cardiovascular diseases.
- Open Access
- 30 May 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 2(46)
PREDICTING AFFECTIVE EPISODES THROUGH DIGITAL MONITORING OF CIRCADIAN RHYTHM DISTURBANCES: A SYSTEMATIC REVIEW OF MODERN TECHNOLOGY APPLICATIONS
Introduction: Affective disorders are serious, long-lasting, and often relapsing conditions that strike an individual unpredictably. The ideal psychiatric monitoring mechanism would predict coming episodes before their full-blown clinical symptoms develop. This would be a tremendous advance and may be possible using our current understanding of the nature of affective disorders, portable device-based data collection capabilities, and remote data analysis. There are numerous reviews of the literature that cover the symptom recognition of affective disorders using mobile devices, but there are no reviews on the actual prediction of affective episodes. This review aims to cover that gap. Methods: A systematic review of five databases (2016-2025) was conducted and included 10 observational studies, mostly designed as prospective cohorts, that concentrated on the prognosis of affective disorders and utilized wearable devices. The variables under study were circadian parameters, sleep metrics, amounts and intensity of physical activity, and light exposure. Although the methodological diversity among the studies made direct comparisons problematic, the studies allowed for the identification of certain findings that appear promising for predicting the occurrence of affective episodes. Results: The review encompassed 10 observational studies (1416 subjects). Our synthesis showed that it is possible, even feasible, to predict affective episodes using mathematical models. These models assess the types of characteristic disturbances that individuals with affective disorders have in their circadian rhythms. When we applied some standard methods for doing this kind of analysis (Accuracy Metrics and AUC Values), the results gave us AUC values that ranged from about 0.67 to 0.98, depending on several factors. Conclusions: Predicting affective episodes is possible using wearable technology or smartphone app, which can detect disturbances in a person's circadian rhythm. Currently, the best methods for doing this merit a look because they could indeed allow for early intervention before the onset of manic or depressive symptoms.
- 30 May 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 2(46)
Open AccessPREDICTING AFFECTIVE EPISODES THROUGH DIGITAL MONITORING OF CIRCADIAN RHYTHM DISTURBANCES: A SYSTEMATIC REVIEW OF MODERN TECHNOLOGY APPLICATIONS
Introduction: Affective disorders are serious, long-lasting, and often relapsing conditions that strike an individual unpredictably. The ideal psychiatric monitoring mechanism would predict coming episodes before their full-blown clinical symptoms develop. This would be a tremendous advance and may be possible using our current understanding of the nature of affective disorders, portable device-based data collection capabilities, and remote data analysis. There are numerous reviews of the literature that cover the symptom recognition of affective disorders using mobile devices, but there are no reviews on the actual prediction of affective episodes. This review aims to cover that gap. Methods: A systematic review of five databases (2016-2025) was conducted and included 10 observational studies, mostly designed as prospective cohorts, that concentrated on the prognosis of affective disorders and utilized wearable devices. The variables under study were circadian parameters, sleep metrics, amounts and intensity of physical activity, and light exposure. Although the methodological diversity among the studies made direct comparisons problematic, the studies allowed for the identification of certain findings that appear promising for predicting the occurrence of affective episodes. Results: The review encompassed 10 observational studies (1416 subjects). Our synthesis showed that it is possible, even feasible, to predict affective episodes using mathematical models. These models assess the types of characteristic disturbances that individuals with affective disorders have in their circadian rhythms. When we applied some standard methods for doing this kind of analysis (Accuracy Metrics and AUC Values), the results gave us AUC values that ranged from about 0.67 to 0.98, depending on several factors. Conclusions: Predicting affective episodes is possible using wearable technology or smartphone app, which can detect disturbances in a person's circadian rhythm. Currently, the best methods for doing this merit a look because they could indeed allow for early intervention before the onset of manic or depressive symptoms.
- 27 April 2025
- Published by European Scientific Society in Archiv Euromedica
- Vol. 15 (2)
A Review of Non-Motor Symptoms in Parkinson’s Disease and Their Influence on Quality of Life
Purpose: This literature-based review explores the multifaceted impact of Parkinson’s disease (PD) on patients’ quality of life, with particular emphasis on non-motor symptoms. Building upon the findings of Karlsen et al., the article integrates contemporary evidence to highlight the role of chronic pain, sleep disturbances, fatigue, depression, emotional dysfunction, and social isolation in shaping patient well-being. Methods: The review centers on the prospective study conducted by Karlsen et al. (1993–1997), which used the Nottingham Health Profile (NHP) to assess health-related quality of life in 111 patients with PD. Supplementary sources from recent decades, were analysed to provide an updated perspective on non-motor symptom prevalence, clinical relevance, and management strategies. These sources include data on physical activity, emotional health, digital health tools, and interdisciplinary care models. Results: Non-motor symptoms frequently have a more significant negative impact on daily functioning and subjective quality of life than motor symptoms. These include not only chronic pain and sleep disturbances but also persistent fatigue, mood disorders, social disengagement, and reduced physical activity. Despite their prevalence, non-motor symptoms remain underrecognized and undertreated in clinical practice. Conclusions: A holistic, multidisciplinary approach is essential for improving quality of life in patients with PD. Effective management should combine pharmacological therapies with psychological support, physical rehabilitation, group-based interventions, and the use of wearable technologies. Future research should prioritize the development of integrated care models, the use of disease-specific quality-of-life assessment tools, and targeted strategies for fatigue, depression, and endocrine comorbidities such as hypothyroidism.
- 27 April 2025
- Published by European Scientific Society in Archiv Euromedica
- Vol. 15 (2)
A Review of Non-Motor Symptoms in Parkinson’s Disease and Their Influence on Quality of Life
Purpose: This literature-based review explores the multifaceted impact of Parkinson’s disease (PD) on patients’ quality of life, with particular emphasis on non-motor symptoms. Building upon the findings of Karlsen et al., the article integrates contemporary evidence to highlight the role of chronic pain, sleep disturbances, fatigue, depression, emotional dysfunction, and social isolation in shaping patient well-being. Methods: The review centers on the prospective study conducted by Karlsen et al. (1993–1997), which used the Nottingham Health Profile (NHP) to assess health-related quality of life in 111 patients with PD. Supplementary sources from recent decades, were analysed to provide an updated perspective on non-motor symptom prevalence, clinical relevance, and management strategies. These sources include data on physical activity, emotional health, digital health tools, and interdisciplinary care models. Results: Non-motor symptoms frequently have a more significant negative impact on daily functioning and subjective quality of life than motor symptoms. These include not only chronic pain and sleep disturbances but also persistent fatigue, mood disorders, social disengagement, and reduced physical activity. Despite their prevalence, non-motor symptoms remain underrecognized and undertreated in clinical practice. Conclusions: A holistic, multidisciplinary approach is essential for improving quality of life in patients with PD. Effective management should combine pharmacological therapies with psychological support, physical rehabilitation, group-based interventions, and the use of wearable technologies. Future research should prioritize the development of integrated care models, the use of disease-specific quality-of-life assessment tools, and targeted strategies for fatigue, depression, and endocrine comorbidities such as hypothyroidism.